An interview with Dr. Rebecca Auer Wednesday, October 10, 2018 Why are cancer clinical trials important? Dr. Auer discusses some of the upcoming #TrialsThatMatter in the rectal cancer space including CO.28, CRC.7 and the exciting potential of immunotherapy. Dr. Rebecca Auer is a surgical oncologist and translational researcher studying the impact of surgery on the immune system and subsequent cancer recurrence at the Ottawa Hospital. She is the co-chair of the CCTG Rectal Disease Orientated Group.
